Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Muzi

Showing results (11-20 of 89) with videos related to

Pageof 9
Sort By:
Nuclear Medicine and Biology|October 7, 2004
Metabolism of 3'-deoxy-3'-[F-18]fluorothymidine in proliferating A549 cells: validations for positron emission tomographyJohn R Grierson, Jeffery L Schwartz, Mark Muzi, et al.
Nuclear Medicine and Biology|October 26, 2005
True tracers: comparing FDG with glucose and FLT with thymidineKenneth A Krohn, David A Mankoff, Mark Muzi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 10, 2003
18F-Fluorothymidine radiation dosimetry in human PET imaging studiesHubert Vesselle, John Grierson, Lanell M Peterson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 8, 2005
Kinetic modeling of 3'-deoxy-3'-fluorothymidine in somatic tumors: mathematical studiesMark Muzi, David A Mankoff, John R Grierson, et al.
The Annals of Applied Statistics|November 14, 2014
VOXEL-LEVEL MAPPING OF TRACER KINETICS IN PET STUDIES: A STATISTICAL APPROACH EMPHASIZING TISSUE LIFE TABLESFinbarr O'Sullivan, Mark Muzi, David A Mankoff, et al.
Molecular Imaging and Biology|June 11, 2008
NCI-sponsored trial for the evaluation of safety and preliminary efficacy of FLT as a marker of proliferation in patients with recurrent gliomas: safety studiesAlexander M Spence, Mark Muzi, Jeanne M Link, et al.
Clinical Imaging|February 8, 2018
Inter-operator variability in compartmental kinetic analysis of <sup>18</sup>F-fluoromisonidazole dynamic PETSadek A Nehmeh, Jazmin Schwartz, Milan Grkovski, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 7, 2004
Comparison of different quantitative approaches to 18F-fluoride PET scansWinfried Brenner, Cheryl Vernon, Mark Muzi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 21, 2009
Imaging of cyclosporine inhibition of P-glycoprotein activity using 11C-verapamil in the brain: studies of healthy humansMark Muzi, David A Mankoff, Jeanne M Link, et al.
Tomography (Ann Arbor, Mich.)|April 14, 2020
Assessment of the Prognostic Value of Radiomic Features in <sup>18</sup>F-FMISO PET Imaging of Hypoxia in Postsurgery Brain Cancer Patients: Secondary Analysis of Imaging Data from a Single-Center Study and the Multicenter ACRIN 6684 TrialMark Muzi, Eric Wolsztynski, James R Fink, et al.
Pageof 9

Showing results (11-20 of 89) with videos related to

Sort By:
Pageof 9
Nuclear Medicine and Biology|October 7, 2004
Metabolism of 3'-deoxy-3'-[F-18]fluorothymidine in proliferating A549 cells: validations for positron emission tomographyJohn R Grierson, Jeffery L Schwartz, Mark Muzi, et al.
Nuclear Medicine and Biology|October 26, 2005
True tracers: comparing FDG with glucose and FLT with thymidineKenneth A Krohn, David A Mankoff, Mark Muzi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 10, 2003
18F-Fluorothymidine radiation dosimetry in human PET imaging studiesHubert Vesselle, John Grierson, Lanell M Peterson, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 8, 2005
Kinetic modeling of 3'-deoxy-3'-fluorothymidine in somatic tumors: mathematical studiesMark Muzi, David A Mankoff, John R Grierson, et al.
The Annals of Applied Statistics|November 14, 2014
VOXEL-LEVEL MAPPING OF TRACER KINETICS IN PET STUDIES: A STATISTICAL APPROACH EMPHASIZING TISSUE LIFE TABLESFinbarr O'Sullivan, Mark Muzi, David A Mankoff, et al.
Molecular Imaging and Biology|June 11, 2008
NCI-sponsored trial for the evaluation of safety and preliminary efficacy of FLT as a marker of proliferation in patients with recurrent gliomas: safety studiesAlexander M Spence, Mark Muzi, Jeanne M Link, et al.
Clinical Imaging|February 8, 2018
Inter-operator variability in compartmental kinetic analysis of <sup>18</sup>F-fluoromisonidazole dynamic PETSadek A Nehmeh, Jazmin Schwartz, Milan Grkovski, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 7, 2004
Comparison of different quantitative approaches to 18F-fluoride PET scansWinfried Brenner, Cheryl Vernon, Mark Muzi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 21, 2009
Imaging of cyclosporine inhibition of P-glycoprotein activity using 11C-verapamil in the brain: studies of healthy humansMark Muzi, David A Mankoff, Jeanne M Link, et al.
Tomography (Ann Arbor, Mich.)|April 14, 2020
Assessment of the Prognostic Value of Radiomic Features in <sup>18</sup>F-FMISO PET Imaging of Hypoxia in Postsurgery Brain Cancer Patients: Secondary Analysis of Imaging Data from a Single-Center Study and the Multicenter ACRIN 6684 TrialMark Muzi, Eric Wolsztynski, James R Fink, et al.
Pageof 9